Asmussen C, Gutensohn K, Wittkopf D, Kühnl P
Abteilung für Transfusionsmedizin, Transplantationsimmunologie, Universitäts-Krankenhaus Eppendorf, Hamburg, Germany.
Beitr Infusionsther Transfusionsmed. 1996;33:35-9.
Red blood cell (RBC)-bound IgG can cause hemolysis resulting, e.g. in severe cases of autoimmune hemolytic anemias (AIHA) or in hemolytic disease of the newborn (HDN). Serologic detection and differentiation of these antibodies are often difficult in cases of low antibody titers. We investigated 36 cases of poly- and monospecific IgG-positive DATs by flow cytometry. The RBC samples were washed, diluted, and incubated with monoclonal antibodies directed against IgG1, IgG2, IgG3, and IgG4, respectively. Analysis was performed on a flow cytometer. Nine cases were negative for all 4 IgG subclasses, 8 cases were positive for IgG2, 5 for IgG1, 5 for IgG3, and 3 for all four subclasses. In 6 patients we found combinations of 2 or 3 subclasses (2 for IgG1 and IgG2, 1 for IgG1 and IgG3, 1 for IgG3 and IgG4, 1 for IgG1, IgG2 and IgG4, 1 for IgG1, IgG3 and IgG4). Serological differentiation revealed specific anti-bodies only in 3 cases (anti-Lea, anti-Leb, anti-P1). The type of IgG subclass and the amount of RBC-bound IgG is relevant for the degree of in vivo RBC destruction. Flow cytometry provides a rapid, highly sensitive, cost efficient, and specific tool for IgG detection, including subgroups.
We therefore recommend flow cytometric analysis to be integrated into the serological decision process as an additional method for serological problem cases.
红细胞(RBC)结合的IgG可导致溶血,例如在自身免疫性溶血性贫血(AIHA)的严重病例或新生儿溶血病(HDN)中。在抗体滴度较低的情况下,这些抗体的血清学检测和鉴别往往很困难。我们通过流式细胞术研究了36例多特异性和单特异性IgG阳性直接抗球蛋白试验(DAT)病例。将红细胞样本洗涤、稀释,然后分别与针对IgG1、IgG2、IgG3和IgG4的单克隆抗体孵育。在流式细胞仪上进行分析。9例所有4种IgG亚类均为阴性,8例IgG2阳性,5例IgG1阳性,5例IgG3阳性,3例所有4种亚类均阳性。在6例患者中,我们发现了2种或3种亚类的组合(2例为IgG1和IgG2,1例为IgG1和IgG3,1例为IgG3和IgG4,1例为IgG1、IgG2和IgG4,1例为IgG1、IgG3和IgG4)。血清学鉴别仅在3例中发现特异性抗体(抗-Lea、抗-Leb、抗-P1)。IgG亚类的类型和RBC结合的IgG量与体内RBC破坏程度相关。流式细胞术为IgG检测(包括亚组)提供了一种快速、高度敏感、经济高效且特异的工具。
因此,我们建议将流式细胞术分析作为血清学疑难病例的一种额外方法纳入血清学诊断流程。